These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 14107118)

  • 1. THE EFFECT OF THE NEW F.D.A. REGULATIONS ON THE DRUG INDUSTRY.
    BEYER KH
    Clin Pharmacol Ther; 1964; 5():1-5. PubMed ID: 14107118
    [No Abstract]   [Full Text] [Related]  

  • 2. NEW DRUG REGULATIONS--A YEAR'S PERSPECTIVE.
    STETLER CJ
    New Physician; 1964 Mar; 13():75-7. PubMed ID: 14126411
    [No Abstract]   [Full Text] [Related]  

  • 3. RULES, REGULATIONS AND RESEARCH.
    NEIBEL OJ
    New Physician; 1963 Dec; 12():A85-A87. PubMed ID: 14103668
    [No Abstract]   [Full Text] [Related]  

  • 4. REFLECTIONS: F.D.A. AND THE DRUG INDUSTRY.
    STANFILL RC
    Bull Parenter Drug Assoc; 1964; 18():28-33. PubMed ID: 14107091
    [No Abstract]   [Full Text] [Related]  

  • 5. IMPACT OF FDA REGULATIONS ON PSYCHOPHARMACOLOGY.
    GALLAGHER JD
    SD J Med Pharm; 1964 Apr; 17():38-42. PubMed ID: 14139180
    [No Abstract]   [Full Text] [Related]  

  • 6. REGULATIONS AFFECTING DRUG RESEARCH AND DEVELOPMENT: A HISTORICAL PERSPECTIVE.
    KLUMPP TG
    J New Drugs; 1963; 3(4):212-20. PubMed ID: 14063357
    [No Abstract]   [Full Text] [Related]  

  • 7. RECENT DRUG LEGISLATION IN THE UNITED STATES.
    AESCHLIMANN J
    Pharm Acta Helv; 1964; 39():193-6. PubMed ID: 14246809
    [No Abstract]   [Full Text] [Related]  

  • 8. PROBLEMS IN DRUG DEVELOPMENT AS THEY RELATE TO THE PHARMACEUTICAL INDUSTRY.
    WINTER IC
    J New Drugs; 1964; 4(6):306-11. PubMed ID: 14247771
    [No Abstract]   [Full Text] [Related]  

  • 9. CONTROL OF DRUG TOXICITY IN THE UNITED STATES OF AMERICA.
    WESTON JK; WESTON K
    Practitioner; 1965 Jan; 194():16-21. PubMed ID: 14259685
    [No Abstract]   [Full Text] [Related]  

  • 10. LEGAL, LEGISLATIVE AND REGULATORY PROBLEMS OF THE PHARMACEUTICAL INDUSTRY.
    STETLER CJ
    Rocky Mt Med J; 1965 Aug; 62():58-61. PubMed ID: 14318988
    [No Abstract]   [Full Text] [Related]  

  • 11. THE USE OF EXPERIMENTAL DRUGS AND TECHNICS.
    WASMUTH CE
    Anesth Analg; 1964; 43():187-9. PubMed ID: 14164940
    [No Abstract]   [Full Text] [Related]  

  • 12. THE PHYSICIAN AS FINAL ARBITER?
    PAGE I
    Appl Ther; 1964 Apr; 6():293-5. PubMed ID: 14152073
    [No Abstract]   [Full Text] [Related]  

  • 13. THE INVESTIGATIONAL DRUG BRANCH: A REVIEW OF OBJECTIVES AND FUNCTION.
    KELSEY FO
    J New Drugs; 1963; 3(4):250-5. PubMed ID: 14063363
    [No Abstract]   [Full Text] [Related]  

  • 14. RECENT EXPERIENCES WITH EFFECTIVE NEW DRUG APPLICATIONS.
    MEYERS EL
    Bull Parenter Drug Assoc; 1964; 18():1-6. PubMed ID: 14224959
    [No Abstract]   [Full Text] [Related]  

  • 15. THE NEW DRUG REGULATIONS AND THE PHARMACEUTICAL INDUSTRY.
    KIRSCH WE
    Proc West Pharmacol Soc; 1963; 6():48-52. PubMed ID: 14062834
    [No Abstract]   [Full Text] [Related]  

  • 16. The evolution of new drug legislation.
    Kelsey FO
    BMQ; 1966 Sep; 17(3):72-81. PubMed ID: 5978212
    [No Abstract]   [Full Text] [Related]  

  • 17. PROGRESS ON INVESTIGATIONAL DRUGS.
    RANKIN WB
    J New Drugs; 1963; 3(6):377-80. PubMed ID: 14113562
    [No Abstract]   [Full Text] [Related]  

  • 18. NEW DRUG SURVEILLANCE IN 1964.
    ELLENHORN MJ
    J New Drugs; 1964; 4(3):166-75. PubMed ID: 14185008
    [No Abstract]   [Full Text] [Related]  

  • 19. THE THIRD YEAR.
    NODINE JH
    Curr Ther Res Clin Exp; 1965 Feb; 7():150-6. PubMed ID: 14260089
    [No Abstract]   [Full Text] [Related]  

  • 20. PLANNING IN THE FOOD AND DRUG ADMINISTRATION FOR REGULATION OF PRESCRIPTION DRUG ADVERTISING.
    SADUSK JF
    Curr Ther Res Clin Exp; 1965 May; 7():332-6. PubMed ID: 14286216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.